Progress to Further Commercialisation - updates, page-7

I just try to understand what the business is doing in terms of progressing milestones and less about the daily share price fluctuations. I feel it's highly likely that the business will be significantly more substantial in terms of htert sales Siennet sales, collaborations with private companies such as minomic and even closer to ovarian diagnostic and b2m sales etc in 12 months. The share price will follow. The board members have been buying a few shares recently which in my view is a positive sign that confidence is there and the major shareholders are still heavily invested. Its frustrating to see nervous retail investors selling bits and pieces causing the share price to drop but it is completely unrelated to where the business is at. Bd1 has so many more great products in development now than it did prior to the merger some fantastic major shareholders to back it, money in the bank and an excellent leadership team with a huge addressable market. I can't see any negatives to the business atm. If that changes then fair enough to sell but until then ....im holding.